Skip to main content
Erschienen in: Journal of Assisted Reproduction and Genetics 7/2014

01.07.2014 | Assisted Reproduction Technologies

Prolonged gonadotropin stimulation for assisted reproductive technology cycles is associated with decreased pregnancy rates for all women except for women with polycystic ovary syndrome

verfasst von: Amanda Ryan, Shunping Wang, Ruben Alvero, Alex J Polotsky

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine if etiology of infertility modifies the relationship between the duration of ovarian stimulation and success during assisted reproductive technology (ART) cycles.

Methods

A prospectively collected database was analyzed in an academic infertility practice. Eight hundred and twelve infertile women undergoing their initial fresh embryo, non-donor in vitro fertilization (IVF) or Intracytoplasmic Sperm Injection ICSI) cycle between January 1999 and December 2010 were evaluated. Clinical pregnancy was the main outcome measured.

Results

Out of 663 cycles resulting in oocyte retrieval, 299 produced a clinical pregnancy (45.1%). Women who achieved a clinical pregnancy had a significantly shorter stimulation length (11.9 vs. 12.1 days, p=0.047). Polycystic ovary syndrome (PCOS) was the only etiology of infertility that was significantly associated with a higher chance for clinical pregnancy and was a significant confounder for the association of duration and success of treatment. Women with 13 days or longer of stimulation had a 34 % lower chance of clinical pregnancy as compared to those who had a shorter cycle (OR 0.66, 95% CI:0.46-0.95) after adjustment for age, ovarian reserve, number of oocytes retrieved, embryos transferred and PCOS diagnosis.

Conclusion

Prolonged duration of stimulation is associated with decreased ART success for all couples, except for women with PCOS.
Literatur
2.
Zurück zum Zitat Kushnir VA, Vidali A, Barad DH, Gleicher N. The status of public reporting of clinical outcomes in assisted reproductive technology. Fertility and Sterility 2013;100:736–741. Kushnir VA, Vidali A, Barad DH, Gleicher N. The status of public reporting of clinical outcomes in assisted reproductive technology. Fertility and Sterility 2013;100:736–741.
3.
Zurück zum Zitat Younglai EV, Holloway AC, Foster WG. Environmental and occupational factors affecting fertility and IVF success. Hum Reprod Update. 2005;11:43–57.PubMedCrossRef Younglai EV, Holloway AC, Foster WG. Environmental and occupational factors affecting fertility and IVF success. Hum Reprod Update. 2005;11:43–57.PubMedCrossRef
4.
Zurück zum Zitat Chuang M, Zapantis A, Taylor M, Jindal SK, Neal-Perry GS, Lieman HJ, et al. Prolonged gonadotropin stimulation is associated with decreased ART success. J Assist Reprod Genet. 2010;27:711–7.PubMedCentralPubMedCrossRef Chuang M, Zapantis A, Taylor M, Jindal SK, Neal-Perry GS, Lieman HJ, et al. Prolonged gonadotropin stimulation is associated with decreased ART success. J Assist Reprod Genet. 2010;27:711–7.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Baker VL, Luke B, Brown MB, Alvero R, Frattarelli JL, Usadi R, et al. Multivariate analysis of factors affecting probability of pregnancy and live birth with in vitro fertilization: an analysis of the society for assisted reproductive technology clinic outcomes reporting system. Fertil Steril. 2010;94:1410–6.PubMedCrossRef Baker VL, Luke B, Brown MB, Alvero R, Frattarelli JL, Usadi R, et al. Multivariate analysis of factors affecting probability of pregnancy and live birth with in vitro fertilization: an analysis of the society for assisted reproductive technology clinic outcomes reporting system. Fertil Steril. 2010;94:1410–6.PubMedCrossRef
6.
Zurück zum Zitat Urman B, Tiras B, Yakin K. Assisted reproduction in the treatment of polycystic ovarian syndrome. Reprod Biomed Online. 2004;8:419–30.PubMedCrossRef Urman B, Tiras B, Yakin K. Assisted reproduction in the treatment of polycystic ovarian syndrome. Reprod Biomed Online. 2004;8:419–30.PubMedCrossRef
7.
Zurück zum Zitat Mulders AG, Laven JS, Imani B, Eijkemans MJ, Fauser BC. IVF outcome in anovulatory infertility (WHO group 2)–including polycystic ovary syndrome–following previous unsuccessful ovulation induction. Reprod Biomed Online. 2003;7:50–8.PubMedCrossRef Mulders AG, Laven JS, Imani B, Eijkemans MJ, Fauser BC. IVF outcome in anovulatory infertility (WHO group 2)–including polycystic ovary syndrome–following previous unsuccessful ovulation induction. Reprod Biomed Online. 2003;7:50–8.PubMedCrossRef
8.
Zurück zum Zitat Hardy K, Robinson FM, Paraschos T, Wicks R, Franks S, Winston RM. Fertilization and early embryology: normal development and metabolic activity of preimplantation embryos in vitro from patients with polycystic ovaries. Hum Reprod. 1995;10:2125–35.PubMed Hardy K, Robinson FM, Paraschos T, Wicks R, Franks S, Winston RM. Fertilization and early embryology: normal development and metabolic activity of preimplantation embryos in vitro from patients with polycystic ovaries. Hum Reprod. 1995;10:2125–35.PubMed
9.
Zurück zum Zitat Heijnen EM, Eijkemans MJ, Hughes EG, Laven JS, Macklon NS, Fauser BC. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12:13–21.PubMedCrossRef Heijnen EM, Eijkemans MJ, Hughes EG, Laven JS, Macklon NS, Fauser BC. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12:13–21.PubMedCrossRef
10.
Zurück zum Zitat Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley; 2000.CrossRef Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley; 2000.CrossRef
11.
Zurück zum Zitat Homburg R, Howles C. Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rational, results, reflections refinements. Hum Reprod Update. 1999;5:493–9.PubMedCrossRef Homburg R, Howles C. Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rational, results, reflections refinements. Hum Reprod Update. 1999;5:493–9.PubMedCrossRef
12.
Zurück zum Zitat Andoh K, Mizunuma H, Liu X, Kamijo T, Yamada K, Ibuki Y. A comparative study of fixed-dose, step-down, and low-dose step-up regimens of human menopausal gonadotropin for patients with polycystic ovary syndrome. Fertil Steril. 1998;70:840–6.PubMedCrossRef Andoh K, Mizunuma H, Liu X, Kamijo T, Yamada K, Ibuki Y. A comparative study of fixed-dose, step-down, and low-dose step-up regimens of human menopausal gonadotropin for patients with polycystic ovary syndrome. Fertil Steril. 1998;70:840–6.PubMedCrossRef
13.
Zurück zum Zitat Tanbo T, Åbyholm T, Bjøro T, Dale PO. Ovarian stimulation in previous failures from in-vitro fertilization: distinction of two groups of poor responders. Hum Reprod. 1990;5:811–5.PubMed Tanbo T, Åbyholm T, Bjøro T, Dale PO. Ovarian stimulation in previous failures from in-vitro fertilization: distinction of two groups of poor responders. Hum Reprod. 1990;5:811–5.PubMed
14.
Zurück zum Zitat Okohue J, Onuh S, Ikimalo J. Comparison of IVF/ICSI outcome in patients with polycystic ovarian syndrome or tubal factor infertility. Niger J Clin Pract. 2013;16:207–10.PubMedCrossRef Okohue J, Onuh S, Ikimalo J. Comparison of IVF/ICSI outcome in patients with polycystic ovarian syndrome or tubal factor infertility. Niger J Clin Pract. 2013;16:207–10.PubMedCrossRef
15.
Zurück zum Zitat Beydoun HA, Stadtmauer L, Beydoun MA, Russell H, Zhao Y, Oehninger S. Polycystic ovary syndrome, body mass index and outcomes of assisted reproductive technologies. Reprod Biomed Online. 2009;18:856–63.PubMedCentralPubMedCrossRef Beydoun HA, Stadtmauer L, Beydoun MA, Russell H, Zhao Y, Oehninger S. Polycystic ovary syndrome, body mass index and outcomes of assisted reproductive technologies. Reprod Biomed Online. 2009;18:856–63.PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Dale PO, Tanbo T, Åbyholm T. In-vitro fertilization in infertile women with the polycystic ovarian syndrome. Hum Reprod. 1991;6:238–41.PubMed Dale PO, Tanbo T, Åbyholm T. In-vitro fertilization in infertile women with the polycystic ovarian syndrome. Hum Reprod. 1991;6:238–41.PubMed
17.
Zurück zum Zitat Swanton A, Storey L, McVeigh E, Child T. IVF outcome in women with PCOS, PCO and normal ovarian morphology. Eur J Obstet Gynecol Reprod Biol. 2010;149:68–71.PubMedCrossRef Swanton A, Storey L, McVeigh E, Child T. IVF outcome in women with PCOS, PCO and normal ovarian morphology. Eur J Obstet Gynecol Reprod Biol. 2010;149:68–71.PubMedCrossRef
18.
Zurück zum Zitat Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab. 2004;89:318–23.PubMedCrossRef Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab. 2004;89:318–23.PubMedCrossRef
19.
Zurück zum Zitat Pall M, Stephens K, Azziz R. Family size in women with polycystic ovary syndrome. Fertil Steril. 2006;85:1837–9.PubMedCrossRef Pall M, Stephens K, Azziz R. Family size in women with polycystic ovary syndrome. Fertil Steril. 2006;85:1837–9.PubMedCrossRef
20.
Zurück zum Zitat Pal L, Jindal S, Witt BR, Santoro N. Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertil Steril. 2008;89:1694–701.PubMedCentralPubMedCrossRef Pal L, Jindal S, Witt BR, Santoro N. Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertil Steril. 2008;89:1694–701.PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Chen SL, Sun L, Kong LH, Li L, Li J, Zhu L, et al. Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization. Zhonghua Fu Chan Ke Za Zhi. 2007;42:526–9.PubMed Chen SL, Sun L, Kong LH, Li L, Li J, Zhu L, et al. Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization. Zhonghua Fu Chan Ke Za Zhi. 2007;42:526–9.PubMed
22.
Zurück zum Zitat Rittenberg V, Seshadri S, Sunkara SK, Sobaleva S, Oteng-Ntim E, El-Toukhy T. Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis. Reprod Biomed Online. 2011;23:421–39.PubMedCrossRef Rittenberg V, Seshadri S, Sunkara SK, Sobaleva S, Oteng-Ntim E, El-Toukhy T. Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis. Reprod Biomed Online. 2011;23:421–39.PubMedCrossRef
23.
Zurück zum Zitat Jungheim ES, Lanzendorf SE, Odem RR, Moley KH, Chang AS, Ratts VS. Morbid obesity is associated with lower clinical pregnancy rates after in vitro fertilization in women with polycystic ovary syndrome. Fertil Steril. 2009;92:256–61.PubMedCentralPubMedCrossRef Jungheim ES, Lanzendorf SE, Odem RR, Moley KH, Chang AS, Ratts VS. Morbid obesity is associated with lower clinical pregnancy rates after in vitro fertilization in women with polycystic ovary syndrome. Fertil Steril. 2009;92:256–61.PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat Navot D, Rosenwaks Z, Margalioth E. Prognostic assessment of female fecundity. Lancet. 1987;330:645–7.CrossRef Navot D, Rosenwaks Z, Margalioth E. Prognostic assessment of female fecundity. Lancet. 1987;330:645–7.CrossRef
Metadaten
Titel
Prolonged gonadotropin stimulation for assisted reproductive technology cycles is associated with decreased pregnancy rates for all women except for women with polycystic ovary syndrome
verfasst von
Amanda Ryan
Shunping Wang
Ruben Alvero
Alex J Polotsky
Publikationsdatum
01.07.2014
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 7/2014
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-014-0253-9

Weitere Artikel der Ausgabe 7/2014

Journal of Assisted Reproduction and Genetics 7/2014 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.